Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$282,873,054
-$98,105,507 QoQ
Shares Held
1,113,805
-28.5% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#162
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Boston Partners holds $3,635,506,449 across 12 Drug Manufacturers - General names. JNJ ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,784,316 | $1,203,925,277 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,017,958 | $760,308,811 | |
| 3 | AZN |
Astrazeneca PLC
|
3,177,627 | $602,541,630 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
1,113,805 | $282,873,054 | |
| 5 | BIIB |
Biogen Inc.
|
1,263,429 | $272,976,467 | |
| 6 | AMGN |
Amgen Inc
|
637,923 | $231,004,675 | |
| 7 | SNY |
Sanofi
|
3,844,844 | $164,021,044 | |
| 8 | MRK |
Merck & Co., Inc.
|
629,240 | $80,857,340 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $282,873,054 | 1,113,805 | Shares | Other | 2026-08-04 | |
| 2026-03-31 | $380,978,561 | 1,558,577 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $327,835,494 | 1,584,129 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $301,749,725 | 1,627,385 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $259,488,797 | 1,698,781 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $291,761,481 | 1,759,295 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $327,284,748 | 2,263,067 | Shares | Other | 2025-02-11 | |
| 2024-09-30 | $296,482,287 | 1,829,460 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $262,228,577 | 1,794,120 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $287,832,239 | 1,819,535 | Shares | Other | 2024-05-28 | |
| 2023-12-31 | $297,504,743 | 1,898,078 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $317,778,591 | 2,040,312 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $1,119,561,387 | 6,763,904 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,177,146,725 | 7,594,495 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,532,275,523 | 8,674,076 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,476,916,684 | 9,040,871 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $1,607,606,177 | 9,056,426 | Shares | Other | 2022-08-10 | |
| 2022-03-31 | $1,482,410,204 | 8,364,330 | Shares | Other | 2022-05-10 | |
| 2021-12-31 | $1,365,245,516 | 7,980,625 | Shares | Other | 2022-02-04 | |
| 2021-09-30 | $1,260,618,772 | 7,805,689 | Shares | Other | 2021-11-05 | |
| 2021-06-30 | $1,272,001,359 | 7,721,266 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $1,207,357,994 | 7,346,261 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $1,143,048,104 | 7,262,982 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,021,620,067 | 6,862,037 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $831,504,405 | 5,912,710 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $849,225,285 | 6,476,209 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||